NEW
YORK, July 11, 2024 /PRNewswire/ -- The global
medical devices market size is estimated to grow by USD 194.3 billion from 2024-2028, at a CAGR of
6.07%, according to Technavio. Key drivers include the increasing
prevalence of diseases and the emergence of innovative medical
technologies. However, declining reimbursement and cost containment
measures pose challenges. Major players include Abbott
Laboratories, B. Braun SE, Baxter International Inc., Becton Dickinson and Co., Boston Scientific
Corp., Canon Inc., Cardinal Health Inc., Danaher Corp., and
others.
Get a detailed analysis on regions, market
segments, customer landscape, and companies - Click for the
snapshot of this report
Forecast
period
|
2024-2028
|
Base Year
|
2023
|
Historic
Data
|
2018 - 2022
|
Segment
Covered
|
End-user (Hospitals and
ASCs, Clinics, and Others), Product (Therapeutic and surgical,
PMDMID, and Others), and Geography (North America, Europe, Asia,
and Rest of World (ROW))
|
Region
Covered
|
North America, Europe,
Asia, and Rest of World (ROW)
|
Key companies
profiled
|
Abbott Laboratories,
B.Braun SE, Baxter International Inc., Becton Dickinson and Co.,
Boston Scientific Corp., Canon Inc., Cardinal Health Inc., Danaher
Corp., F. Hoffmann La Roche Ltd., Fresenius SE and Co. KGaA,
General Electric Co., Johnson and Johnson Services Inc.,
Koninklijke Philips N.V., Medtronic Plc, Nihon Kohden Corp.,
Olympus Corp., Siemens AG, Smith and Nephew plc, Stryker Corp., and
Zimmer Biomet Holdings Inc.
|
Key Market Trends Fueling Growth
The medical devices market is experiencing significant growth
due to the introduction of innovative technologies such as
regenerative medicine, surgical robots, liquid biopsy, and wearable
medical devices. Regenerative medicine, including therapies using
stem cells, tissue engineering, and artificial organs, is gaining
prominence for its potential to repair or replace damaged human
cells, tissues, and organs. Surgical robots offer advantages like a
3D view of the operating field, reduced risk of infections, quick
recovery, and precision in surgery. Liquid biopsy, an advanced
diagnostic method in cancer diagnosis, is non-invasive and helps
create personalized treatment plans by tracking cancer genetics in
real-time. Wearable medical devices, used for pain management,
patient assistance, and fetal monitoring, are driving market growth
in various applications. Vendors are focusing on developing novel
surgical robots and liquid biopsy technologies, while wearable
medical devices continue to expand their reach in
healthcare.
The medical devices market is experiencing significant growth
due to the rising prevalence of chronic diseases like cancer and
diabetes. Changing lifestyles and an ageing population are driving
the demand for healthcare solutions, including wearable electronics
and wireless medical devices. Smart technologies, such as fitness
trackers, are popular among athletes and individuals seeking to
monitor their health. Cancer cases and related deaths continue to
increase, leading to a surge in demand for therapeutic and
diagnostic devices. Hospitals are investing in capital equipment
for surgical procedures, while home healthcare and medical clothing
are gaining traction. The Medicines Agency and healthcare agencies
are working to approve breakthrough designs for medical devices,
from pacemakers and insulin pumps to implantable defibrillators.
The economic burden of healthcare is driving innovation in areas
like cardiovascular diseases, infectious diseases, and sedentary
lifestyles. RunRepeat reports that elective surgeries, dental
procedures, and orthopedic surgeries are common applications for
medical devices. Overall, the market for medical devices is
diverse, encompassing inpatient admissions, emergency room visits,
and outpatient procedures.
Discover 360° analysis of this market. For
complete information, schedule your consultation- Book
Here!
Market Challenges
- The medical devices market is facing significant challenges due
to increasing cost-containment measures implemented by governments
and insurance providers in major markets, including the US, EU, and
Japan. These measures include
limiting reimbursements for certain procedures or treatments,
shifting to population health management, and introducing new laws
and regulations. For instance, the US Sunshine Act requires
manufacturers to report annual spending on physicians and
continuing education activities to the Centers for Medicare and
Medicaid Services (CMS), impacting medical communications and
clinical data collection activities. Non-compliance with these
programs can result in severe financial penalties, legal conflicts,
and damage to brand image. Governments are also introducing price
controls, limiting access to or reimbursement for products, and
reducing intellectual property protection. The misalignment of
reimbursement rates and the value of medical technologies is a
significant challenge, as reimbursement values are often based on
procedure costs rather than technology or features. This can
prevent the development of advanced technologies that reduce costs
and improve outcomes in the long run. The industry is transitioning
from a volume-based to a value-based model, requiring medical
device companies to provide comprehensive evidence of the
real-world value and positive outcomes of their products. Private
insurers demand cost-effectiveness and clinical benefits data for
new medical devices, and those that fail to provide such data often
struggle to generate investor support or attain reimbursements.
This shift poses a challenge for medical companies in fields such
as cardiovascular and orthopedics, where reimbursements are vital
for product sales. The declining reimbursements for certain
procedures have restricted access to new and expensive implants for
many end-users, requiring companies to allocate substantial
resources for cost-effective trials to demonstrate the benefits of
their devices to insurance providers. The refusal of payments by
third-party payers is significantly affecting sales and overall
profitability of vendors operating in the market. These
cost-containment measures are expected to hinder the growth of the
global medical devices market during the forecast period.
- The medical devices market encompasses a wide range of
products, including insulin pumps and implantable defibrillators.
These devices face challenges in areas like surgical procedures for
cardiovascular diseases, cancer, and diabetes. Regulatory bodies
like Medicines Agencies and healthcare agencies play a crucial role
in approving diagnostic tools and medical equipment, such as
capital equipment, consumables, and wearable devices. Elective
surgeries and emergency room visits for chronic disorders like
diabetes and infectious diseases pose challenges due to increasing
inpatient admissions. The ageing population and sedentary
lifestyles contribute to a rise in ophthalmic and orthopedic
procedures, further increasing the demand for medical devices. The
economic burden of these procedures and the need for home
healthcare have led to the development of breakthrough designs for
medical devices. Dental procedures, cardiovascular equipment, and
surgical lights are also essential medical devices with growing
demand. Companies like RunRepeat focus on supplying medical
clothing, masks, gloves, and fetal monitors to meet the needs of
healthcare providers.
For more insights on driver and
challenges - Download a Sample Report
Segment Overview
This medical devices market report extensively covers market
segmentation by
- End-user
- 1.1 Hospitals and ASCs
- 1.2 Clinics
- 1.3 Others
- Product
- 2.1 Therapeutic and surgical
- 2.2 PMDMID
- 2.3 Others
- Geography
- 3.1 North America
- 3.2 Europe
- 3.3 Asia
- 3.4 Rest of World (ROW)
1.1 Hospitals and ASCs- The Medical Devices
Market is a significant sector, experiencing consistent growth.
Companies manufacture and sell various devices to diagnose,
monitor, and treat medical conditions. These devices include
cardiac monitors, insulin pumps, and imaging systems. Market size
and growth are influenced by factors like technological
advancements, aging population, and increasing healthcare
expenditure. Companies focus on innovation, regulatory compliance,
and cost-effectiveness to gain a competitive edge.
For more information on market segmentation with
geographical analysis including forecast (2024-2028) and historic
data (2018 - 2022) - Download a Sample Report
Research Analysis
The medical devices market is experiencing significant growth
due to the rising prevalence of chronic diseases such as
cardiovascular diseases, cancer, and diabetes. Changing lifestyles,
including sedentary work and unhealthy diets, are contributing to
an increase in chronic disorders. Wearable electronics, wireless
medical technologies, and smart technologies are revolutionizing
health monitoring, with applications ranging from fitness trackers
for athletes to therapeutic and diagnostic devices for hospitals.
Cancer cases and related deaths continue to rise, driving demand
for innovative medical devices in cancer treatment and diagnosis.
Hospitals are integrating advanced medical technologies, including
pacemakers, insulin pumps, and implantable defibrillators, into
surgical procedures. The ageing population and economic burden of
healthcare are also fueling demand for home healthcare solutions,
medical clothing, masks, and gloves. Infectious diseases and
ophthalmic and orthopedic procedures are other areas of focus for
medical device innovation.
Market Research Overview
The medical devices market is experiencing significant growth
due to the rising prevalence of chronic diseases such as
cardiovascular diseases, cancer, and diabetes. Changing lifestyles,
including sedentary habits and unhealthy diets, are contributing to
an increase in these conditions. Healthcare agencies and the
Medicines Agency are working to address this trend through the
development and approval of innovative medical devices. Wearable
electronics, wireless medical technologies, and smart technologies
are transforming healthcare by enabling remote health monitoring
and early disease detection. Fitness trackers and other wearable
devices are increasingly popular among athletes and the general
population for monitoring health and fitness. Cancer cases and
related deaths continue to be a major concern, with diagnostic and
therapeutic devices playing a crucial role in improving patient
outcomes. Pacemakers, insulin pumps, and implantable defibrillators
are just a few examples of therapeutic devices that are making a
significant impact on healthcare. Surgical procedures, including
cardiovascular, ophthalmic, orthopedic, and dental procedures, are
driving demand for capital equipment and consumables. Hospitals and
home healthcare settings are the primary markets for these devices.
Breakthrough designations and economic burden are key
considerations for healthcare agencies when approving new medical
devices. Elective surgeries and emergency room visits are major
contributors to healthcare costs, making the development of
cost-effective and efficient medical devices a priority. Medical
clothing, masks, gloves, surgical lights, fetal monitors, and other
medical devices are essential components of healthcare, supporting
a wide range of medical procedures and applications. The aging
population is also driving demand for medical devices in areas such
as home healthcare and assisted living.
Table of Contents:
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation
- End-user
-
- Hospitals And ASCs
- Clinics
- Others
- Product
-
- Therapeutic And Surgical
- PMDMID
- Others
- Geography
-
- North America
- Europe
- Asia
- Rest Of World (ROW)
7 Customer Landscape
8 Geographic Landscape
9 Drivers, Challenges, and Trends
10 Company Landscape
11 Company Analysis
12 Appendix
About Technavio
Technavio is a leading global technology research and advisory
company. Their research and analysis focuses on emerging market
trends and provides actionable insights to help businesses identify
market opportunities and develop effective strategies to optimize
their market positions.
With over 500 specialized analysts, Technavio's report library
consists of more than 17,000 reports and counting, covering 800
technologies, spanning across 50 countries. Their client base
consists of enterprises of all sizes, including more than 100
Fortune 500 companies. This growing client base relies on
Technavio's comprehensive coverage, extensive research, and
actionable market insights to identify opportunities in existing
and potential markets and assess their competitive positions within
changing market scenarios.
Contacts
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/
View original content to download
multimedia:https://www.prnewswire.com/news-releases/medical-devices-market-size-is-set-to-grow-by-usd-194-3-billion-from-2024-2028--increasing-prevalence-of-diseases-to-boost-the-market-growth-technavio-302194642.html
SOURCE Technavio